Cell Therapy for Chronic TBI: Interim Analysis of the Randomized Controlled STEMTRA Trial.

Masahito KawaboriAlan H WeintraubHideaki ImaiLaroslav ZinkevychPeter McAllisterGary K SteinbergBenjamin M FrishbergTakao YasuharaJefferson W ChenSteven C CramerAchal S AchrolNeil E SchwartzJun SuenagaDaniel C LuIhor SemenivHajime NakamuraDouglas KondziolkaDai ChidaTakehiko KanekoYasuaki KarasawaSusan PaadreBijan NejadnikDamien BatesAnthony H StonehouseRobert Mark RichardsonDavid O Okonkwo

Published in: Neurology (2021)

This study provides Class I evidence that implantation of SB623 was well tolerated and associated with improvement in motor status.

Keyphrases

cell therapy
phase iii
phase ii
traumatic brain injury
open label
stem cells
double blind
clinical trial
mesenchymal stem cells
study protocol
randomized controlled trial
bone marrow
severe traumatic brain injury